The structures of oligosaccharides isolated from the lipopolysaccharide of Moraxella catarrhalis serotype B, strain CCUG 3292
- PMID: 9002189
- DOI: 10.1016/s0008-6215(96)90132-9
The structures of oligosaccharides isolated from the lipopolysaccharide of Moraxella catarrhalis serotype B, strain CCUG 3292
Abstract
The oligosaccharides from the lipopolysaccharides of Moraxella catarrhalis serotype B, strain CCUG 3292, were isolated after mild acid hydrolysis and separated by high-performance anion-exchange chromatography. The structures of the oligosaccharides were established by fast atom bombardment mass spectrometry and nuclear magnetic resonance spectroscopy. It is concluded that the oligosaccharides comprise a mixture of mainly a nona- and a deca-saccharide. [formula: see text] Smaller amounts of undeca-saccharides and of truncated forms, namely, hexa-, hepta-, and octa-saccharides, were also detected.
Similar articles
-
Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C.Carbohydr Res. 1995 Jan 17;266(2):237-61. doi: 10.1016/0008-6215(94)00276-l. Carbohydr Res. 1995. PMID: 7535189
-
Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238).Carbohydr Res. 1994 May 5;257(2):269-84. doi: 10.1016/0008-6215(94)80040-5. Carbohydr Res. 1994. PMID: 7516823
-
A conformational carbohydrate scaffold is present in the short-chain lipopolysaccharides of Moraxella catarrhalis.Angew Chem Int Ed Engl. 2004 Apr 19;43(17):2288-90. doi: 10.1002/anie.200353581. Angew Chem Int Ed Engl. 2004. PMID: 15108147 No abstract available.
-
The lipopolysaccharide of moraxella catarrhalis structural relationships and antigenic properties.Eur J Biochem. 1999 Oct;265(2):524-9. doi: 10.1046/j.1432-1327.1999.00731.x. Eur J Biochem. 1999. PMID: 10504382 Review.
-
Glycoconjugates: overview and strategy.Methods Enzymol. 1990;193:539-53. doi: 10.1016/0076-6879(90)93437-p. Methods Enzymol. 1990. PMID: 2074835 Review. No abstract available.
Cited by
-
Moraxella catarrhalis: from emerging to established pathogen.Clin Microbiol Rev. 2002 Jan;15(1):125-44. doi: 10.1128/CMR.15.1.125-144.2002. Clin Microbiol Rev. 2002. PMID: 11781271 Free PMC article. Review.
-
Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.Infect Immun. 2000 Sep;68(9):5261-8. doi: 10.1128/IAI.68.9.5261-5268.2000. Infect Immun. 2000. PMID: 10948153 Free PMC article.
-
Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.Infect Immun. 2005 May;73(5):2790-6. doi: 10.1128/IAI.73.5.2790-2796.2005. Infect Immun. 2005. PMID: 15845482 Free PMC article.
-
An Unusual Carbohydrate Conformation is Evident in Moraxella catarrhalis Oligosaccharides.Molecules. 2015 Aug 5;20(8):14234-53. doi: 10.3390/molecules200814234. Molecules. 2015. PMID: 26251889 Free PMC article.
-
Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading.Glycoconj J. 2010 Oct;27(7-9):643-8. doi: 10.1007/s10719-010-9309-y. Epub 2010 Oct 5. Glycoconj J. 2010. PMID: 20922476
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases